Ampio Pharmaceuticals, Inc.

AMPE · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$9-$16-$17-$16
Dep. & Amort.$0$1$1$1
Deferred Tax$0$0-$3$0
Stock-Based Comp.$0$1$3$1
Change in WC-$1-$3$3-$2
Other Non-Cash$1-$4$0$1
Operating Cash Flow-$9-$21-$14-$15
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$0$31$26
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$2-$1
Financing Cash Flow$0-$0$31$26
Forex Effect$0$0$0$0
Net Chg. in Cash-$9-$21$17$11
Supplemental Information
Beg. Cash$13$34$17$7
End Cash$4$13$34$17
Free Cash Flow-$9-$21-$14-$15